Mechanisms of Fever-Enhanced Hyperoxic Lung Injury
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury
批准号:
6581997
负责人:
JEFFREY D HASDAY
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-03-01 至 2007-02-28
关键词:
SDS polyacrylamide gel electrophoresis apoptosis cell migration clinical research colony stimulating factor cytotoxicity enzyme linked immunosorbent assay flow cytometry heat shock proteins human tissue hyperoxia hyperthermia in situ hybridization inflammation laboratory mouse leukocyte activation /transformation longitudinal animal study lung injury lymphocyte monocyte polymerase chain reaction tissue /cell culture
中文摘要
描述(由申请人提供):我们发现,暴露于发热范围高温(FRH)通过增加肺内嗜中性粒细胞(PMN)的蓄积,显著加速肺氧中毒的发作和进展。 FRH激活G-CSF表达,扩大循环PMN库,增强跨内皮迁移,并增加高氧肺内CXC趋化因子KC和LIX的产生。 初步数据表明,热休克反应,通常被认为是保护应激细胞,有助于增加肺损伤的高温,高氧肺。 我们推测,FRH和高氧的会聚导致早期和广泛的肺损伤,部分介导的过程中,没有激活的刺激单独。 我们将使用我们的高氧暴露,温度控制的小鼠模型和小鼠和人类细胞培养系统,以阐明FRH和高氧之间的协同作用,导致肺损伤的机制。 具体而言,我们将:
1)确定FRH如何扩大和启动循环PMN池,(第1-4年):确定过热小鼠中过量G-CSF的来源,并阐明其表达增加的分子机制;分析PMN去边缘化、粒细胞生成增加和PMN存活延长的贡献;并确定FRH是否启动循环PMN的募集和细胞毒性。
2)阐明FRH增加PMN向高氧肺内输送和改变PMN分布的机制(1-4岁):确定KC和LIX的细胞来源,阐明其表达增加和PMN向肺组织再分布的分子机制;确定FRH是否抑制PMN凋亡,增加PMN坏死和细胞毒性颗粒释放。
3)确定高温、高氧肺中热休克的激活如何反常地导致肺损伤(2-5年):确定PMN内细胞内热休克蛋白(HSP)的产生是否有助于从PMN凋亡到坏死的转变;以及从受损细胞释放的细胞外HSP-60或-70是否通过其TLR 4依赖性促炎作用增强肺损伤。拟议的研究将为重症患者发烧的意外后果提供新的见解,并扩大我们对发烧改变免疫反应机制的了解。
英文摘要
DESCRIPTION (provided by applicant): We showed that exposure to febrile range hyperthermia (FRH) markedly accelerates onset and progression of pulmonary oxygen toxicity by augmenting accumulation of neutrophils (PMN) within lung interstitium. FRH activates G-CSF expression, expands the circulating PMN pool, enhances transendothelial migration, and augments generation of the CXC chemokines, KC and LIX, within the hyperoxic lung. Preliminary data suggest that the heat shock response, usually thought to be protective in stressed cells, contributes to the augmented lung injury in the hyperthermic, hyperoxic lung. We hypothesize that the convergence of FRH and hyperoxia causes early and extensive lung injury mediated, in part, by processes that are not activated by either stimulus alone. We will use our hyperoxia-exposed, temperature-controlled mouse model and mouse and human cell culture systems to elucidate the mechanisms underlying the synergism between FRH and hyperoxia in causing lung injury. Specifically, we will:
1) Determine how FRH expands and primes the circulating PMN pool, (years 1-4): identify the source of excess G-CSF in hyperthermic mice and elucidate the molecular mechanisms of its increased expression; analyze the contributions of PMN demargination, increased granulopoiesis, and prolonged PMN survival; and determine whether FRH primes circulating PMN for recruitment and cytotoxicity.
2) Elucidate the mechanisms through which FRH augments PMN delivery to and alters PMN distribution within the hyperoxic lung (years 1-4): identify cellular sources of KC and LIX and elucidate the molecular mechanisms of their increased expression and of the redistribution of PMN to lung interstitium; and determine if FRH inhibits PMN apoptosis, and increases PMN necrosis and cytotoxic granule release.
3) Determine how activation of heat shock in the hyperthermic, hyperoxic lung paradoxically worsens lung injury (years 2-5): determine if generation of intracellular heat shock proteins (HSP) within PMN contribute to shift from PMN apoptosis to necrosis; and whether extracellular HSP-60 or -70 released from injured cells augments lung injury through their TLR4-dependent proinflammatory actions. The proposed studies will provide new insights about the unanticipated consequences of fever in critically ill patients, and expand our knowledge about the mechanisms through which fever modifies the immune response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome
-
批准号:10535453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:JEFFREY D HASDAY
-
依托单位:
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome
-
批准号:10367545
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:JEFFREY D HASDAY
-
依托单位:
Hyperthermia-augmented epithelial apoptosis and acute lung injury
-
批准号:8542278
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:JEFFREY D HASDAY
-
依托单位:
Hyperthermia-augmented epithelial apoptosis and acute lung injury
-
批准号:8974334
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:JEFFREY D HASDAY
-
依托单位:
Hyperthermia-augmented epithelial apoptosis and acute lung injury
-
批准号:8721706
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:JEFFREY D HASDAY
-
依托单位:
Novel Mechanisms of Smooth Muscle Beta2-receptor Regulation Relevant to Asthma
-
批准号:8661247
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2010
-
负责人:JEFFREY D HASDAY
-
依托单位:
The contribution of heat shock/stress pathways to acute lung injury
-
批准号:7264065
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2007
-
负责人:JEFFREY D HASDAY
-
依托单位:
The contribution of heat shock/stress pathways to acute lung injury
-
批准号:7386621
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2007
-
负责人:JEFFREY D HASDAY
-
依托单位:
The contribution of heat shock/stress pathways to acute lung injury
-
批准号:7586229
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2007
-
负责人:JEFFREY D HASDAY
-
依托单位:
The contribution of heat shock/stress pathways to acute lung injury
-
批准号:7780051
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2007
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of HSF1-mediated Repression of TNF-alpha
-
批准号:6875575
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2004
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of HSF1-mediated Repression of TNF-alpha
-
批准号:7037583
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2004
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of HSF1-mediated Repression of TNF-alpha
-
批准号:6782434
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2004
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of HSF1-mediated Repression of TNF-alpha
-
批准号:7112554
-
项目类别:
-
资助金额:$6.24万
-
财政年份:2004
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of HSF1-mediated Repression of TNF-alpha
-
批准号:7227045
-
项目类别:
-
资助金额:$30.57万
-
财政年份:2004
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of Fever-Enhanced Acute Lung Injury
-
批准号:7673491
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2003
-
负责人:JEFFREY D HASDAY
-
依托单位:
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury
-
批准号:8911921
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2003
-
负责人:JEFFREY D HASDAY
-
依托单位:
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury
-
批准号:8690132
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2003
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of Fever-Enhanced Acute Lung Injury
-
批准号:8102930
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2003
-
负责人:JEFFREY D HASDAY
-
依托单位:
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury
-
批准号:6864887
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:JEFFREY D HASDAY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: